secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alpha Teknova, Inc. (TKNO)
CIK:        0001850902
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0000950170-25-031995
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teknova reports FY2024 revenue $37.7M (+3% YoY), guides FY2025 $39-42M, amends credit facility
--------------------------------------------------------------------------------

- FY2024 revenue $37.7M (+3% YoY); Q4 revenue $9.3M (+18% YoY). Clinical Solutions Q4 revenue $1.85M (+110% YoY).
- Net loss FY2024 $26.7M ($0.57/share) vs $36.8M ($1.16) in FY2023; adjusted EBITDA -$14.5M vs -$19.8M.
- 2025 guidance: revenue $39-42M, free cash outflow <$12M (vs -$13.5M in FY2024).
- New $28.245M credit facility ($23.245M term + $5M revolver), maturity March 2030, principal pay starting April 2028.
- Covenants: minimum net revenue $39M for TTM ending Dec 2025; minimum cash $8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850902/000095017025031995/0000950170-25-031995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850902/000095017025031995/tkno-20250304.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-031995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer